First Mercantile Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,140
Closed -$269K 890
2020
Q4
$269K Buy
1,140
+370
+48% +$84.9K 0.03% 316
2020
Q3
$172K Sell
770
-130
-14% -$35.9K 0.02% 476
2020
Q2
$261K Buy
+900
New +$244K 0.03% 301
2020
Q1
Sell
-765
Closed -$167K 907
2019
Q4
$167K Buy
+765
New +$155K 0.02% 524
2016
Q2
Sell
-1,632
Closed -$130K 926
2016
Q1
$130K Sell
1,632
-1,058
-39% -$95.7K 0.02% 677
2015
Q4
$338K Sell
2,690
-343
-11% -$41.4K 0.03% 549
2015
Q3
$316K Sell
3,033
-1,014
-25% -$130K 0.03% 570
2015
Q2
$500K Sell
4,047
-364
-8% -$45.9K 0.04% 505
2015
Q1
$520K Sell
4,411
-1,182
-21% -$142K 0.04% 483
2014
Q4
$664K Buy
5,593
+446
+9% +$50.2K 0.06% 424
2014
Q3
$578K Buy
5,147
+2,395
+87% +$228K 0.05% 485
2014
Q2
$261K Buy
+2,752
New +$193K 0.02% 670
2014
Q1
Sell
-4,150
Closed -$308K 1308
2013
Q4
$308K Sell
4,150
-400
-9% -$27.9K 0.02% 677
2013
Q3
$345K Sell
4,550
-100
-2% -$7.96K 0.03% 640
2013
Q2
$371K Buy
+4,650
New +$342K 0.03% 612

Other funds holding VRTX